Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adverum Biotechnlgs (NQ: ADVM )

8.960 USD +0.100 (+1.13%)
Official Closing Price Updated: 4:21 PM EDT, Apr 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 665,800
Open 8.830
Bid (Size) 8.600 (10)
Ask (Size) 11.70 (2)
Prev. Close 8.860
Today's Range 8.695 - 9.110
52wk Range 8.580 - 26.98
Shares Outstanding 97,796,128
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Adverum Biotechnologies to Present New Data from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at ARVO 2021
From GlobeNewswire News Releases
Adverum Files Definitive Proxy Materials and Mails Letter to Stockholders Detailing Strength of Team and Acceleration Toward Commercialization of ADVM-022
From GlobeNewswire News Releases

Performance

YTD
-25.21%
-25.21%
1 Month
-17.27%
-17.27%
3 Month
-26.38%
-26.38%
6 Month
-22.49%
-22.49%
1 Year
-36.27%
-36.27%

More News

Read More
The Sonic Fund II, L.P. Files Definitive Proxy Statement and Sends Letter to Stockholders of Adverum Biotechnologies, Inc.
From Business Wire News Releases
The Sonic Fund II, L.P. Files Preliminary Proxy Statement Relating to the Election of Highly Qualified Independent Directors at the 2021 Annual Meeting of Adverum Biotechnologies, Inc.
From PR Newswire
Adverum Announces Senior Appointments for Patient Access and Clinical Operations as ADVM-022 Advances Toward Global Phase 3 Trials
From GlobeNewswire News Releases
Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value Creation
From GlobeNewswire News Releases
Interesting ADVM Put And Call Options For December 17th
Tags Stocks
From Market News Video
Adverum Announces Shortened Timelines and Clear Development Path for ADVM-022 Intravitreal Gene Therapy in Wet AMD, Reports Recent Business Progress and Fourth Quarter 2020 Financial Results
From GlobeNewswire News Releases
Analysts Predict 10% Gains Ahead For The Holdings of KOMP
Tags ETFs
From ETF Channel
Friday 3/26 Insider Buying Report: ADVM, AFCG
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.